AI assistant
Solana Co — Director's Dealing 2017
Apr 19, 2017
32724_dirs_2017-04-19_be3821c5-fd6e-438d-9c04-d71b3ab33a95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2017-04-17
Reporting Person: GRIFFIN THOMAS E (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-17 | Stock Option (Right to Buy) | $1.63 | A | 100000 | Acquired | 2027-04-17 | Class A Common Stock (100000) | Direct |
Footnotes
F1: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16
F2: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.